Price, one year
Price range
- Open
- ₹1,987.50
- High
- ₹2,009.60
- Low
- ₹1,933.50
- Previous close
- ₹2,002.50
- Volume
- 18.9 L
- Market cap
- ₹1,06,442 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 97.2
- Price to book
- 20.1
- Return on equity
- 20.6%
- EPS (TTM)
- ₹20.26
- Book value / share
- ₹98.09
- Debt to equity
- 0.44
- Revenue (TTM)
- ₹7,270 Cr
- Net profit (TTM)
- ₹1,093 Cr
- Sales growth, YoY
- +29.1%
- Profit growth, YoY
- +125.5%
- Operating margin
- 28.0%
- Net margin
- 15.0%
- Sales CAGR, 3 years
- +4.1%
- Profit CAGR, 3 years
- +4.0%
- Promoter holding
- 27.47%
- Promoter shares pledged
- 2.19%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 27.49 | 27.47 | 27.47 |
| Foreign institutions | 25.82 | 28.00 | 30.84 |
| Domestic institutions | 13.97 | 13.74 | 11.86 |
| Mutual funds | 11.22 | 10.15 | 8.26 |
| Retail and others | 21.25 | 20.49 | 20.03 |
| Promoter pledge | 2.69 | 2.69 | 2.19 |
Futures and options
23 Oct 2026- Lot size
- 850
- Put-call ratio (OI)
- 0.58
- Max pain
- ₹2,000.00
- Highest call OI strike
- 2,100.00
- Highest put OI strike
- 1,900.00
- ATM implied volatility
- 36.7% IV rank 70
- Futures basis
- −0.12%
- Rollover
- 68.0%
Futures open interest, last sessions
| Date | Build-up | Price | OI change |
|---|---|---|---|
| 23 Oct | Long unwinding | −1.94% | −1.10% |
| 22 Oct | Long unwinding | −0.03% | −1.13% |
| 21 Oct | Short buildup | −2.86% | +0.92% |
| 19 Oct | Short covering | +0.12% | −1.40% |
| 16 Oct | Short covering | +1.67% | −1.44% |
Option figures are for the 27 Oct 2026 expiry.
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 24 Jul 2026. dividend,results: 29 Oct 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
| LupinLUPIN | ₹1,928.90 | +0.36% |
Frequently asked questions
What is the share price of Laurus Labs today?
Laurus Labs (NSE: LAURUSLABS) was at ₹1,970.00 on 23 Oct 2026, a change of −1.62% from the previous close.
What are the 52-week high and low of Laurus Labs?
Over the last 52 weeks Laurus Labs traded between ₹864.70 and ₹2,089.00 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Laurus Labs?
About ₹1,06,442 Cr at the latest price, with a P/E of 97.2, a price-to-book of 20.1, a return on equity of 20.6%. Ratios use the company's latest reported results.
Who owns Laurus Labs shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 27.47%, foreign institutions 30.84%, domestic institutions 11.86%.
Is Laurus Labs traded in futures and options?
Yes, LAURUSLABS is in NSE's futures and options segment. The lot size is 850 shares.
Which sector and indices does Laurus Labs belong to?
NSE classifies Laurus Labs under Healthcare; it is a member of Nifty 500.
Follow Laurus Labs with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial